Insider Financial
Biotech
-
217Dimension Therapeutics Inc (NASDAQ:DMTX) Is Soaring: Here’s Why
Here is an interesting one. Back at the end of August, we published this piece in response to the announcement that biotechnology...
-
121Opiant Pharmaceuticals Inc (NASDAQ:OPNT): Buy The Dip
This time last week, we published this piece on Opiant Pharmaceuticals Inc (NASDAQ:OPNT). During the few months previous to our coverage, the...
-
798Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR): Buy The Dip
Up until the middle of this week, Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) had been a real winner for our readers. We first highlighted...
-
926Atossa Genetics Inc (NASDAQ:ATOS) Should Run Into The End Of 2017
It has taken a little longer than we initially expected, but Atossa Genetics Inc (NASDAQ:ATOS) is finally making a comeback in the...
-
750Here’s Our Take On The Inotek Pharmaceuticals Corp (NASDAQ:ITEK) Merger
A couple of months ago, Inotek Pharmaceuticals Corp (NASDAQ:ITEK) reported that it was on the lookout for what it referred to as...
-
1.8KWhat Happens Now At Delcath Systems, Inc. (NASDAQ:DCTH)
What happens now for Delcath Systems, Inc. (NASDAQ:DCTH)? That’s a question being bounced back and forth in the small biotechnology space hundreds...
-
7.6KNeurotrope Inc (NASDAQ:NTRP) Is On The Road To Recovery
Last time we covered Neurotrope Inc (NASDAQ:NTRP), the company had taken a bit of a hit on some trial data and was...
-
1.4KAkari Therapeutics PLC (ADR) (NASDAQ:AKTX) Is A Biotech Stock Runner
We need to talk again about Akari Therapeutics PLC (ADR) (NASDAQ:AKTX), the drug developer, as everybody in the market seems to be...
-
801Here’s Our Revised Thesis On Eleven Biotherapeutics Inc (NASDAQ:EBIO)
Back in May, we looked at Eleven Biotherapeutics Inc (NASDAQ:EBIO) here. At the time, the company had just put out first quarter...